Literature DB >> 17270096

Laboratory testing for C1 inhibitor deficiency: a comparison of two approaches to C1 inhibitor function.

M M Gompels1, R J Lock.   

Abstract

BACKGROUND: C1 inhibitor deficiency may be hereditary or acquired. It is characterized by absent or poorly functioning C1 inhibitor. The disorder is rare, with prevalence estimated at 1/50,000. The very low incidence of the condition makes the sensitivity and specificity of assays used particularly important. Two different methods are commercially available to measure C1 inhibitor function. There are few data comparing these assays.
METHODS: Two assays of C1 inhibitor function (C1 inhibitor-C1s complex formation or inhibition of C1 esterase cleavage of artificial substrate [colorimetric]) were compared in 71 patients (28 hereditary angioedema, 2 acquired angioedema and 41 controls).
RESULTS: Qualitatively, the two assays showed good correspondence (92%). Six of 71 results were discordant. Correlation in quantitative terms was moderate (R = 0.81).
CONCLUSIONS: Both assays show high sensitivity for hereditary/acquired angioedema. The colorimetric assay is more prone to false-positive results. However, clinical interpretation is not adversely affected.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17270096     DOI: 10.1258/000456307779596020

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  3 in total

Review 1.  Clinical Immunology Review Series: An approach to the patient with angio-oedema.

Authors:  S Grigoriadou; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

2.  An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema.

Authors:  M D Tarzi; A Hickey; T Förster; M Mohammadi; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2007-07-05       Impact factor: 4.330

Review 3.  Angioedema Without Wheals: Challenges in Laboratorial Diagnosis.

Authors:  Anete S Grumach; Camila L Veronez; Dorottya Csuka; Henriette Farkas
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.